IBDEI1R8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29790,0)
 ;;=J9041^^116^1483^14^^^^1
 ;;^UTILITY(U,$J,358.3,29790,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29790,1,1,0)
 ;;=1^J9041
 ;;^UTILITY(U,$J,358.3,29790,1,3,0)
 ;;=3^Bortezomib Inj 0.1mg
 ;;^UTILITY(U,$J,358.3,29791,0)
 ;;=J9055^^116^1483^18^^^^1
 ;;^UTILITY(U,$J,358.3,29791,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29791,1,1,0)
 ;;=1^J9055
 ;;^UTILITY(U,$J,358.3,29791,1,3,0)
 ;;=3^Cetuximab Inj 10mg
 ;;^UTILITY(U,$J,358.3,29792,0)
 ;;=J8530^^116^1483^22^^^^1
 ;;^UTILITY(U,$J,358.3,29792,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29792,1,1,0)
 ;;=1^J8530
 ;;^UTILITY(U,$J,358.3,29792,1,3,0)
 ;;=3^Cyclophosphamide Oral 25mg
 ;;^UTILITY(U,$J,358.3,29793,0)
 ;;=J9206^^116^1483^53^^^^1
 ;;^UTILITY(U,$J,358.3,29793,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29793,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,29793,1,3,0)
 ;;=3^Irinotecan Inj 20mg
 ;;^UTILITY(U,$J,358.3,29794,0)
 ;;=J0135^^116^1483^2^^^^1
 ;;^UTILITY(U,$J,358.3,29794,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29794,1,1,0)
 ;;=1^J0135
 ;;^UTILITY(U,$J,358.3,29794,1,3,0)
 ;;=3^Adalimumab Inj 20mg
 ;;^UTILITY(U,$J,358.3,29795,0)
 ;;=Q2050^^116^1483^36^^^^1
 ;;^UTILITY(U,$J,358.3,29795,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29795,1,1,0)
 ;;=1^Q2050
 ;;^UTILITY(U,$J,358.3,29795,1,3,0)
 ;;=3^Doxorubicin Inj 10mg
 ;;^UTILITY(U,$J,358.3,29796,0)
 ;;=J0129^^116^1483^1^^^^1
 ;;^UTILITY(U,$J,358.3,29796,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29796,1,1,0)
 ;;=1^J0129
 ;;^UTILITY(U,$J,358.3,29796,1,3,0)
 ;;=3^Abatacept Inj 10mg
 ;;^UTILITY(U,$J,358.3,29797,0)
 ;;=J0256^^116^1483^4^^^^1
 ;;^UTILITY(U,$J,358.3,29797,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29797,1,1,0)
 ;;=1^J0256
 ;;^UTILITY(U,$J,358.3,29797,1,3,0)
 ;;=3^Alpha 1 Proteinase Inh Inj 10mg
 ;;^UTILITY(U,$J,358.3,29798,0)
 ;;=J0461^^116^1483^7^^^^1
 ;;^UTILITY(U,$J,358.3,29798,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29798,1,1,0)
 ;;=1^J0461
 ;;^UTILITY(U,$J,358.3,29798,1,3,0)
 ;;=3^Atropine Sulfate Inj 0.01mg
 ;;^UTILITY(U,$J,358.3,29799,0)
 ;;=J0881^^116^1483^27^^^^1
 ;;^UTILITY(U,$J,358.3,29799,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29799,1,1,0)
 ;;=1^J0881
 ;;^UTILITY(U,$J,358.3,29799,1,3,0)
 ;;=3^Darbepoetin Alfa Inj 1mcg
 ;;^UTILITY(U,$J,358.3,29800,0)
 ;;=J1094^^116^1483^31^^^^1
 ;;^UTILITY(U,$J,358.3,29800,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29800,1,1,0)
 ;;=1^J1094
 ;;^UTILITY(U,$J,358.3,29800,1,3,0)
 ;;=3^Dexamethason Acetate Inj 1mg
 ;;^UTILITY(U,$J,358.3,29801,0)
 ;;=J1642^^116^1483^45^^^^1
 ;;^UTILITY(U,$J,358.3,29801,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29801,1,1,0)
 ;;=1^J1642
 ;;^UTILITY(U,$J,358.3,29801,1,3,0)
 ;;=3^Heparin Sodium Inj 10 Units
 ;;^UTILITY(U,$J,358.3,29802,0)
 ;;=J2405^^116^1483^72^^^^1
 ;;^UTILITY(U,$J,358.3,29802,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29802,1,1,0)
 ;;=1^J2405
 ;;^UTILITY(U,$J,358.3,29802,1,3,0)
 ;;=3^Ondansetron HCL Inj 1mg
 ;;^UTILITY(U,$J,358.3,29803,0)
 ;;=J2505^^116^1483^77^^^^1
 ;;^UTILITY(U,$J,358.3,29803,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29803,1,1,0)
 ;;=1^J2505
 ;;^UTILITY(U,$J,358.3,29803,1,3,0)
 ;;=3^Pegfilgrastim Inj 6mg
 ;;^UTILITY(U,$J,358.3,29804,0)
 ;;=J2780^^116^1483^82^^^^1
 ;;^UTILITY(U,$J,358.3,29804,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29804,1,1,0)
 ;;=1^J2780
 ;;^UTILITY(U,$J,358.3,29804,1,3,0)
 ;;=3^Ranitidine Hydrochl Inj 25mg
 ;;^UTILITY(U,$J,358.3,29805,0)
 ;;=J2820^^116^1483^84^^^^1
 ;;^UTILITY(U,$J,358.3,29805,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29805,1,1,0)
 ;;=1^J2820
 ;;^UTILITY(U,$J,358.3,29805,1,3,0)
 ;;=3^Sargramostim Inj 250mcg
